Older patients with chronic urticaria have characteristics that are unique compared with younger patients, such as high rates of autoimmunity and malignancy, according to a study. However, improved awareness of chronic urticaria among these patients with prompt referrals to specialists may improve outcomes, Rasha Khaliliya, MD, allergy and clinical immunology unit, Meir Medical Center, and
Patients with atopic dermatitis treated with dupilumab did not experience any significantly increased risk for a primary or recurrent malignancy, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.“A common question that comes up is whether the biologics that we routinely use in clinical practice, such as dupilumab, are safe in this
AMERICAN SKIN ASSOCIATION ANNOUNCES 2022 RESEARCH GRANTS FOR SKIN CANCER AND DISEASES streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.